Saturday 17 October 2026 Export WEAV’s income statement to Excel — free account

Weave Communications, Inc.

WEAV Healthcare Health Information Services

Weave Communications, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $239.0 million, up 17.0% from fiscal 2024. In the quarter to June 2026, revenue grew 15.5%, EPS grew 54.6%, free cash flow grew 94.3% and total debt rose 4.91%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

7.39 0.00 0.00%

Follow WEAV

Alert me

Market cap: $594.5M
P/E: 0.0×
Fwd P/E: −20.5×
Dividend yield: —
F-score: 6/9
Altman Z: 1.40
Beneish M: −3.19
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.55

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	1	1	—	—	1	—	—	—	—	—	—	—

Insider Ownership 12.64%

Capital & Financial Ratios $m

Market Cap 594.53

Revenue 257.79

Net Income (20.54)

Free Cash Flow 11.02

Net Debt (71.21)

Current Ratio 1.25

Debt/Equity 0.09

P/E ratio 0.00

Fwd P/E (20.50)

P/S ratio 2.28

P/B ratio 6.93

Past 5Y EPS Growth —

This Y EPS Growth 112.50%

Next Y EPS Growth 45.59%

Next Y revenue growth 14.72%

Next 5Y EPS Growth 62.77%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 33.95%

10-year low 10-year high

P/B against its own 10 years 54.03%

10-year low 10-year high

EV/Sales against its own 10 years 44.50%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	109	99	82	78
Receivables	4	4	4	4
Inventory	—	—	—	—
Other	—	—	—	—
	130	121	105	105

	2023	2024	2025	Q'26
Payables	5	8	7	8
ST’ Debt	—	—	—	—
Other	—	—	—	—
	73	77	85	84

Compound Annual Growth %

	10y	5y	3y
Sales	—	24.50%	18.92%
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	(0.34%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	66	68	—	—	—
’25	56	58	61	63	239
’24	47	51	52	54	204
’23	40	42	44	46	170
’22	33	35	36	38	142
’21	26	28	30	32	116
’20	—	18	21	24	80

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(6)	10	—	—	—
’25	0	5	6	6	18
’24	(20)	23	5	7	14
’23	2	2	3	4	10
’22	(4)	(2)	(4)	(3)	(13)
’21	(5)	(2)	(3)	(10)	(20)
’20	—	—	(15)	0	(16)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(7)	9	—	—	—
’25	(1)	4	5	4	13
’24	(21)	21	4	6	10
’23	1	1	2	3	7
’22	(5)	(2)	(5)	(4)	(16)
’21	(8)	(4)	(6)	(12)	(30)
’20	—	—	(17)	(2)	(19)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.07)	(0.05)	—	—	—
’25	(0.12)	(0.11)	(0.11)	(0.02)	(0.37)
’24	(0.10)	(0.12)	(0.08)	(0.09)	(0.40)
’23	(0.12)	(0.13)	(0.10)	(0.10)	(0.46)
’22	(0.21)	(0.23)	(0.18)	(0.14)	(0.76)
’21	(0.75)	(1.08)	(1.03)	(0.34)	(2.60)
’20	—	(0.11)	(0.90)	(0.15)	(3.56)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	13.21	2.91	4.04	8.10	5.64	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	22.40	15.65	12.45	16.56	17.63
People
People	Employees	—	—	—	—	907	889	806	844	854	904
	Revenue/emp, $m	—	—	—	0.00	0.09	0.13	0.18	0.20	0.24	0.26
Income, $m
Income, $m	Revenue	—	—	—	46	80	116	142	170	204	239
	Gross margin, %	—	—	—	59.52	56.88	57.39	62.51	68.10	71.40	72.09
	EBT	—	—	—	(32)	(40)	(52)	(50)	(31)	(28)	(29)
	EBT margin, %	—	—	—	(70.08)	(50.59)	(44.56)	(34.92)	(18.05)	(13.78)	(12.12)
	Net income	—	0	—	(32)	(40)	(52)	(50)	(31)	(28)	(28)
	Depreciation	—	—	—	10	16	22	27	25	27	30
Per share, $
Per share, $	Revenue	—	—	—	4.43	7.04	5.61	2.18	2.52	2.85	3.13
	Earnings	—	—	—	(3.11)	(3.56)	(2.60)	(0.76)	(0.46)	(0.40)	(0.37)
	Cash flow	—	—	—	(2.14)	(1.37)	(0.99)	(0.20)	0.15	0.20	0.23
	Capex	—	—	—	(0.24)	(0.34)	(0.48)	(0.05)	(0.05)	(0.05)	(0.06)
	Free cash flow	—	—	—	(2.38)	(1.71)	(1.46)	(0.24)	0.10	0.14	0.17
	Book value	—	—	—	6.39	(10.03)	5.44	1.28	1.17	0.93	1.08
	Shares, m	—	—	—	10	11	21	65	68	72	76
Valuation, ×
Valuation, ×	P/E	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	—	2.50	2.50	2.70	2.03	4.58	5.58	2.42
	P/B	—	—	—	0.00	0.00	2.79	3.46	9.89	17.03	7.03
	EV/Sales	—	—	—	2.36	2.36	1.75	1.34	4.04	5.18	2.15
	EV/FCF	—	—	—	(12.66)	(12.66)	(6.70)	(12.03)	105.42	102.09	39.94
Cash, $m
Cash, $m	Operating cash flow	—	—	—	(22)	(16)	(20)	(13)	10	14	18
	Capex	—	—	—	(2)	(4)	(10)	(3)	(4)	(4)	(5)
	Free cash flow	—	—	—	(25)	(19)	(30)	(16)	7	10	13
Balance, $m
Balance, $m	Working capital	—	—	—	56	24	100	61	57	44	20
	Total debt	—	—	—	16	11	25	16	6	6	6
	Net debt	—	—	—	(65)	(44)	(111)	(97)	(103)	(93)	(75)
	Shareholders’ equity	—	—	—	66	(114)	112	83	79	67	82
Returns, %
Returns, %	ROA	—	—	—	(61.65)	(41.84)	(38.26)	(25.13)	(15.16)	(14.54)	(14.14)
	ROIC	—	—	—	(1,391.34)	0.00	(2,336.38)	0.00	0.00	0.00	(277.34)
	ROE	—	—	—	34.04	42.56	6,526.89	(50.88)	(38.27)	(38.85)	(37.56)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
HSTM HealthStream, Inc.	$1.0B	46.0×	34.4×	+12.55% (above 0%: growing)	+27.78% (above 0%: growing)	+362.71% (above 0%: growing)	65.35%	9.94%	Compare
PHR Phreesia, Inc.	$685.3M	64.4×	23.5×	+10.41% (above 0%: growing)	+200.00% (above 0%: growing)	+43.51% (above 0%: growing)	66.64%	5.88%	Compare
MDRX Veradigm Inc.	$654.5M	— (loss-making)	— (loss-making)	−9.74% (below 0%: shrinking)	n/m	−66.33% (below 0%: shrinking)	50.53%	(37.41%)	Compare
SOPH SOPHiA GENETICS SA	$620.6M	— (loss-making)	— (loss-making)	+27.22% (above 0%: growing)	n/m	+6.50% (above 0%: growing)	64.61%	(86.03%)	Compare
WEAV Weave Communications, Inc.	$594.5M	— (loss-making)	— (loss-making)	+15.52% (above 0%: growing)	n/m	+94.33% (above 0%: growing)	72.03%	(6.49%)
EVH Evolent Health, Inc	$550.6M	— (loss-making)	— (loss-making)	+46.86% (above 0%: growing)	n/m	+58.67% (above 0%: growing)	12.39%	(1.47%)	Compare
NRC National Research Corporation	$466.9M	80.6×	4.9×	+3.98% (above 0%: growing)	n/m	+101.49% (above 0%: growing)	61.67%	(9.15%)	Compare
CTEV Claritev Corporation	$404.4M	— (loss-making)	— (loss-making)	+6.59% (above 0%: growing)	n/m	+49.10% (above 0%: growing)	73.72%	9.09%	Compare
CARL Carlsmed, Inc.	$380.9M	— (loss-making)	— (loss-making)	+56.75% (above 0%: growing)	n/m	−6.84% (below 0%: shrinking)	76.78%	(58.27%)	Compare
Median of peers	$585.6M	64.4×	23.5×	+11.48%	—	+46.30%	64.98%	(5.31%)

All 51 Health Information Services stocks →